Hunter Syndrome Market

The Hunter Syndrome Market is expected to increase with a CAGR of 7.5% in 7MM during the study period (2017-2030).

The total diagnosed prevalent population of Hunter Syndrome in 7MM was 1,166 in 2017.

The key players in Hunter Syndrome Market include Takeda, JCR Pharmaceuticals, GC Pharma, Regenxbio, Denali Therapeutics, Sangamo Therapeutics, ArmaGen and others.

For more details visit:
https://www.delveinsight.com/report-store/hunter-syndrome-market